Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 33
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Gene ; 265(1-2): 165-73, 2001 Mar 07.
Artículo en Inglés | MEDLINE | ID: mdl-11255019

RESUMEN

To detect the presence of variability in the tandemly repeated sequences of the Epstein-Barr virus latent origin of replication, we analyzed the length of the family of repeats in 14 lymphoblastoid and Burkitt's lymphoma cell lines by PCR amplification. The gel electrophoresis analysis of the PCR products revealed a broad banding pattern, characteristic of each line, consisting of several fragments, sometimes smeared, of variable length. This finding was interpreted as a result of the hairpin-like structures generated by the palindrome within the family of repeats, able to originate artefacts. Since the banding pattern was different only in strictly non-correlated cell lines, we supposed that the sequence of the repeat units was polymorphic. We therefore sequenced the family of repeats in three healthy bone marrow derived lymphoblastoid cell lines carrying an endogenous EBV as well as in a B95-8 infected cell line as control. The sequence analysis revealed that each line is different both in the number and in the sequence of repeats. At the 3' end of the family of repeats the B95-8 virus was found to have a 252 bp region missing in the GenBank standard sequence. This one is probably a partial sequence since it was shorter than the control specimens obtained from different sources of B95-8 DNA analyzed by Southern blot hybridization. The length analysis of the family of repeats can be used to characterize EBV strains by PCR.


Asunto(s)
ADN Viral/genética , Herpesvirus Humano 4/genética , Secuencias Repetitivas de Ácidos Nucleicos/genética , Origen de Réplica , Secuencia de Bases , Southern Blotting , Línea Celular , Heterogeneidad Genética , Humanos , Reacción en Cadena de la Polimerasa , Polimorfismo de Longitud del Fragmento de Restricción , Alineación de Secuencia , Homología de Secuencia de Ácido Nucleico
2.
Biochim Biophys Acta ; 1216(1): 50-4, 1993 Oct 19.
Artículo en Inglés | MEDLINE | ID: mdl-8218415

RESUMEN

The occurrence, upon differentiation, of a transient DNA hypomethylation has been observed in Friend erythroleukemia cells. Treatment with hexamethylenebisacetamide (HMBA) induces within 24 h a 20% hypomethylation of newly synthesized DNA, that is followed by re-methylation before completion of the differentiative process, as measured by the appearance of benzidine-positive cells. We examined a series of mutant clones which continue to grow in the presence of an inducer. Methylcytosine content of DNA was measured by HPLC, after cell labeling with [3H]uridine. We found that one of these continuously growing clones, which was still capable of hemoglobin synthesis, showed the same degree of hypomethylation as the parental one. The re-methylation process did not occur, however, unless erythroid differentiation was reverted by the removal of the inducer. In another clone which had lost the capacity to synthesize hemoglobin, no DNA hypomethylation was detectable. These experiments show that DNA hypomethylation is an early event strictly related to cell differentiation but not to cell growth arrest.


Asunto(s)
ADN/metabolismo , Virus de la Leucemia Murina de Friend , Leucemia Eritroblástica Aguda/genética , Acetamidas/farmacología , Animales , Diferenciación Celular/efectos de los fármacos , Células Clonales , Citosina/análogos & derivados , Citosina/análisis , ADN/biosíntesis , Hemoglobinas/biosíntesis , Leucemia Eritroblástica Aguda/metabolismo , Metilación/efectos de los fármacos , Ratones , Tritio
3.
Physiol Chem Phys Med NMR ; 22(4): 241-5, 1990.
Artículo en Inglés | MEDLINE | ID: mdl-2129308

RESUMEN

The extents of thialysine and selenalysine incorporation into cell proteins were compared in E. coli KL16 and in a mutant able to grow equally well in the presence or in the absence of both lysine analogs. The mutant differs from the parental strain in the repression of aspartokinase III (AKIII), the first enzyme of the lysine biosynthetic pathway. No analog incorporation into proteins was observed in mutant cells grown in the presence of either analog, whereas a marked analog incorporation was observed in the parental strain, where up to 17% and 12% of protein lysine can be substituted by thialysine and selenalysine respectively. In the parental strain grown in media containing either analog at different concentration the extent of analog incorporation into proteins is related to the extent of AKIII repression.


Asunto(s)
Aspartato Quinasa/biosíntesis , Escherichia coli/metabolismo , Lisina/análogos & derivados , Lisina/metabolismo , Compuestos de Organoselenio , Biosíntesis de Proteínas , Aspartato Quinasa/genética , Cisteína/análogos & derivados , Cisteína/metabolismo , Represión Enzimática , Escherichia coli/genética , Isoenzimas , Mutación , Selenio/metabolismo
4.
Biochem Int ; 19(6): 1195-203, 1989 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-2561448

RESUMEN

The extent of protein lysine substitution by thialysine in E. coli cells grown in media containing the analog depends on the time interval the cells are grown in the presence of analog and on the analog concentration in the medium. By calculating the percent of lysine substitution in newly synthesized proteins it was shown that this reaches, after one cell doubling in the presence of analog, a maximum which is 17% in the cells grown with 0.1 or 0.2 mM thialysine and 8% in cells grown with 0.05 mM thialysine. Proteins synthesized in the presence of analog in the concentration range 0.05-0.2 mM show similar stability to those synthesized in the absence of analog. The extent of analog incorporation into newly synthesized proteins, as regards both the time course and the dependence on analog concentration in the medium, is strictly related to the extent of the repression of AK III, the first enzyme of lysine biosynthetic pathway.


Asunto(s)
Aspartato Quinasa/metabolismo , Proteínas Bacterianas/biosíntesis , Cisteína/análogos & derivados , Escherichia coli/metabolismo , Fosfotransferasas/metabolismo , Proteínas Bacterianas/análisis , Cisteína/metabolismo , Escherichia coli/crecimiento & desarrollo , Lisina/análisis , Factores de Tiempo
6.
Biochem Int ; 17(3): 545-54, 1988 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-2849443

RESUMEN

A thialysine-resistant mutant of the E. coli KL16 strain was isolated. It can grow equally well in the presence and in the absence of thialysine. The properties of the two lysine transport systems, of the lysyl-tRNA synthetase and of the aspartokinase III (AK III) were studied in the mutant and in the parent strain. AK III is the first enzyme of the lysine biosynthetic pathway and its activity is involved in the regulation of lysine biosynthesis by feed-back and repression mechanism. No difference between the two strains was evidenced as regards 1) the affinity of the transport systems for lysine and thialysine 2) the activity of the lysyl-tRNA synthetase 3) the allosteric inhibition of the AK III by lysine and thialysine. A marked difference between the two strains has been evidenced in the AK III repression: in the mutant the enzyme is much less repressed both by lysine and thialysine. The possible correlation between the activity of AK III and the thialysine-resistance is discussed in this paper.


Asunto(s)
Aspartato Quinasa/metabolismo , Cisteína/análogos & derivados , Escherichia coli/enzimología , Fosfotransferasas/metabolismo , Aspartato Quinasa/antagonistas & inhibidores , Aspartato Quinasa/genética , Transporte Biológico Activo , Cisteína/farmacología , Farmacorresistencia Microbiana/genética , Escherichia coli/efectos de los fármacos , Escherichia coli/genética , Cinética , Lisina/metabolismo , Lisina/farmacología , Lisina-ARNt Ligasa/metabolismo , Mutación
7.
Biochem Int ; 16(6): 1033-40, 1988 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-3140818

RESUMEN

Thialysine and selenalysine can be utilized for protein synthesis by lysine-requiring E. coli cells even in the absence of lysine. Protein synthesis has been determined as labeled leucine incorporation into acid-insoluble material, as increase of cell proteins and as protein-lysine substitution by the analog. Either analog can be incorporated into proteins, in the absence of lysine, for a limited time interval after which cells stop to duplicate. Proteins synthesized during this period contain most of their lysine residues substituted by the analog. Moreover, it has been shown that the analog-containing proteins are unstable and rapidly degraded. Their instability would account for the inability of lysine-requiring E. coli cells to utilize the analog as growth factor.


Asunto(s)
Proteínas Bacterianas/metabolismo , Cisteína/análogos & derivados , Escherichia coli/metabolismo , Lisina/análogos & derivados , Compuestos de Organoselenio , Selenio/metabolismo , Proteínas Bacterianas/biosíntesis , Cisteína/metabolismo , Escherichia coli/crecimiento & desarrollo , Leucina/biosíntesis , Lisina/metabolismo
8.
Ital J Biochem ; 37(2): 78-84, 1988.
Artículo en Inglés | MEDLINE | ID: mdl-3136092

RESUMEN

In E. coli, Se-3 aminopropylselenocysteine or selenahomolysine (SeHL) does not affect intracellular lysine transport, i.e. it cannot bind E. coli lysine transport systems. In CHO cells it inhibits cationic aminoacid transport system, but only in the presence of Na+, this indicating that it behaves like polar neutral aminoacids. On the other hand, it poorly affects leucine transport both in the presence and in the absence of Na+. SeHL is not activated by aminoacyl-tRNA synthetase preparations from bacterial and mammalian sources, thus it cannot be utilized for protein synthesis.


Asunto(s)
Aminoácidos/metabolismo , Aminoacil-ARNt Sintetasas/metabolismo , Lisina/análogos & derivados , Compuestos de Organoselenio , Selenio/metabolismo , Animales , Arginina/metabolismo , Transporte Biológico , Células Cultivadas , Cricetinae , Cricetulus , Escherichia coli/metabolismo , Lisina/metabolismo , Sodio/farmacología
9.
Physiol Chem Phys Med NMR ; 20(3): 193-7, 1988.
Artículo en Inglés | MEDLINE | ID: mdl-3149757

RESUMEN

A thialysine-resistant mutant of E. coli strain KL16 also shows a lower sensitivity to selenalysine, the lysine analog containing selenium. No difference between the mutant and the parental strain has been shown regarding the affinities of the transport systems and the lysyl-tRNA synthetase for selenalysine, thialysine and lysine as well as the inhibitory effects of these three aminoacids on the activity of the lysine biosynthetic pathway. A marked difference between the two strains has been evidenced in the AK III repression: in the mutant the repression by selenalysine, thialysine and lysine is much lower than in the parental strain.


Asunto(s)
Cisteína/análogos & derivados , Escherichia coli/genética , Lisina/análogos & derivados , Compuestos de Organoselenio , Selenio/farmacología , Aspartato Quinasa/biosíntesis , Cisteína/farmacología , Farmacorresistencia Microbiana , Represión Enzimática , Escherichia coli/efectos de los fármacos , Escherichia coli/enzimología , Cinética , Lisina/farmacología , Lisina-ARNt Ligasa/metabolismo , Mutación
11.
Physiol Chem Phys Med NMR ; 20(2): 109-13, 1988.
Artículo en Inglés | MEDLINE | ID: mdl-3146758

RESUMEN

Thialysine and selenalysine cannot substitute lysine as a growth factor for a lysine-requiring E. coli mutant, but can nevertheless be utilized for protein synthesis in the presence of lysine. In order to have information about the effects of lysine on the utilization of the two analogs, the extent of the incorporation of the three aminoacids into newly synthesized proteins has been determined. The analog starts to be utilized by cells growing in a medium containing either analog and lysine when lysine concentration becomes very low. Of the two analogs, thialysine is more easily utilized. In fact thialysine can be utilized when the lysine/thialysine ratio in the medium is 1/25. Selenalysine starts to be utilized when the lysine/selenalysine ratio is 1/200.


Asunto(s)
Cisteína/análogos & derivados , Escherichia coli/crecimiento & desarrollo , Lisina/análogos & derivados , Lisina/metabolismo , Compuestos de Organoselenio , Selenio/metabolismo , Cisteína/metabolismo , Escherichia coli/genética , Isoleucina/metabolismo , Cinética , Leucina/metabolismo , Mutación
12.
Mutat Res ; 192(3): 221-5, 1987 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-2825008

RESUMEN

The intracellular transport and the activation of lysine, thialysine and selenalysine have been investigated in a thialysine-resistant CHO cell mutant strain in comparison with the parental strain. The cationic amino acid transport system responsible for the transport of these 3 amino acids shows no differences between the 2 strains as regards its affinity for each of these amino acids. On the other hand the Vmax of the transport system in the mutant is about double that in the parental strain. The lysyl-tRNA synthetase, assayed both as ATP = PPi exchange reaction and lysyl-tRNA synthesis, shows a lower affinity for thialysine and selenalysine than for lysine in both strains; in the mutant, however, the difference is even greater. Thus the thialysine resistance of the mutant is mainly due to the properties of its lysyl-tRNA synthetase, which shows a greater difference of the affinities for lysine and thialysine with respect to the parental strain.


Asunto(s)
Cisteína/análogos & derivados , Compuestos de Organoselenio , Adenosina Trifosfato/metabolismo , Animales , Arginina/metabolismo , Transporte Biológico , Cricetinae , Cisteína/metabolismo , Cisteína/toxicidad , Difosfatos/metabolismo , Resistencia a Medicamentos , Cinética , Lisina/análogos & derivados , Lisina/farmacología , Lisina-ARNt Ligasa/antagonistas & inhibidores , Selenio/farmacología
13.
Biochem Int ; 15(5): 971-80, 1987 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-3124854

RESUMEN

CHO cells can incorporate thialysine and selenalysine in their proteins in substitution of lysine. Data are reported in the present paper showing that proteins containing either thialysine or selenalysine are unstable and quite rapidly degraded. The degradation rate is strictly related to the extent of protein lysine substitution. At similar extent of substitution, selenalysine-containing proteins are more unstable that thialysine-containing ones.


Asunto(s)
Cisteína/análogos & derivados , Lisina/análogos & derivados , Compuestos de Organoselenio , Proteínas/metabolismo , Selenio/metabolismo , Aminoácidos/análisis , Animales , Células Cultivadas , Cricetinae , Cricetulus , Cisteína/metabolismo , Isoleucina/metabolismo , Leucina/metabolismo , Lisina/metabolismo , Biosíntesis de Proteínas , Hidrolisados de Proteína/análisis
14.
Biochem Int ; 15(1): 35-43, 1987 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-3134889

RESUMEN

In E. coli aminoethylhomocysteine (AEHC) and aminopropylcysteine (APC) do not affect intracellular lysine transport thus showing that they cannot bind the E. coli lysine transport systems. In CHO cells AEHC and APC inhibit lysine and arginine transport, AEHC more than APC, thus indicating that they can bind the cationic aminoacid transport system. They inhibit also leucine transport, APC more than AEHC. Some possible relationships between their structure and their effects on transport systems are considered. AEHC and APC are not activated by aminoacyl-tRNA synthetase preparations from bacterial and mammalian sources.


Asunto(s)
Aminoácidos/metabolismo , Aminoacil-ARNt Sintetasas/metabolismo , Cisteína/análogos & derivados , Homocisteína/análogos & derivados , Animales , Arginina/metabolismo , Sitios de Unión , Transporte Biológico , Cricetinae , Cricetulus , Cisteína/fisiología , Escherichia coli/metabolismo , Homocisteína/fisiología , Lisina/metabolismo , Relación Estructura-Actividad
15.
Ital J Biochem ; 36(4): 227-32, 1987.
Artículo en Inglés | MEDLINE | ID: mdl-3123419

RESUMEN

CHO cells can incorporate into proteins both thialysine and selenalysine when both are present together in the culture medium. Thialysine and selenalysine inhibit cell growth and cell viability. The inhibitory effect of either analog is additive. The inhibition of cell viability is related to the extent of protein lysine substitution by thialysine or selenalysine; it is however irrelevant whether lysine is substituted by one or the other analog or by both.


Asunto(s)
Cisteína/análogos & derivados , Lisina/análogos & derivados , Compuestos de Organoselenio , Biosíntesis de Proteínas , Selenio/metabolismo , Animales , División Celular , Línea Celular , Supervivencia Celular , Cricetinae , Cisteína/metabolismo , Inhibidores de Crecimiento , Lisina/metabolismo
16.
Physiol Chem Phys Med NMR ; 19(1): 23-7, 1987.
Artículo en Inglés | MEDLINE | ID: mdl-3112812

RESUMEN

The intracellular transport of thialysine and selenalysine in CHO cells has been studied. Data have been obtained indicating that the two lysine analogs can be transported by both the cationic aminoacid transport system and by the L transport system. The affinity of the cationic aminoacid transport system is similar for the two lysine analogs but lower than that for lysine and the affinity of the L transport system for the two lysine analogs is lower than that for leucine.


Asunto(s)
Aminoácidos/metabolismo , Cisteína/análogos & derivados , Lisina/análogos & derivados , Compuestos de Organoselenio , Selenio/metabolismo , Aminoácidos/farmacología , Animales , Transporte Biológico/efectos de los fármacos , Línea Celular , Cricetinae , Cricetulus , Cisteína/metabolismo , Cisteína/farmacología , Femenino , Cinética , Lisina/metabolismo , Lisina/farmacología , Ovario , Selenio/farmacología
17.
Physiol Chem Phys Med NMR ; 19(3): 153-7, 1987.
Artículo en Inglés | MEDLINE | ID: mdl-3126505

RESUMEN

CHO cells allowed to grow in a medium containing selenalysine can utilize it for protein synthesis. Selenalysine is incorporated into cell proteins in substitution of lysine: a maximum of 5% of protein lysine can be substituted. Protein lysine substitution by selenalysine can be correlated to the reduced viability of cells grown in its presence.


Asunto(s)
Lisina/análogos & derivados , Compuestos de Organoselenio , Selenio/metabolismo , Animales , Línea Celular , Cricetinae , Cricetulus , Femenino , Cinética , Lisina/metabolismo , Lisina/farmacología , Ovario
18.
Microbiologica ; 9(4): 487-92, 1986 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-3095610

RESUMEN

A thialisyne resistant variant clone of CHO cells also shows a lower sensitivity to selenasyne, the lysine analog containing selenium. Growth rate, cell viability and protein synthesis rate are less affected by selenasyne in the variant compared to the parental strain. Data are reported showing that during cellular growth of either strain some toxic derivatives of selenasyne are produced and accumulated in the culture medium even in the presence of excess lysine.


Asunto(s)
División Celular/efectos de los fármacos , Cisteína/análogos & derivados , Lisina/análogos & derivados , Compuestos de Organoselenio , Selenio/farmacología , Animales , Línea Celular , Supervivencia Celular/efectos de los fármacos , Células Clonales , Medios de Cultivo , Cisteína/farmacología , Resistencia a Medicamentos , Lisina/farmacología , Biosíntesis de Proteínas
19.
Mol Cell Biochem ; 59(1-2): 149-54, 1984.
Artículo en Inglés | MEDLINE | ID: mdl-6423960

RESUMEN

Thialysine cannot completely substitute lysine as growth factor for a lysine-requiring E. coli mutant. However it can be utilized for growth in the presence of limiting amounts of lysine, in substitution of, and in competition with this latter. The effects of thialysine on growth rate, protein synthesis rate and cell viability, and its incorporation into proteins were studied in function of lysine and thialysine concentration in the culture media. Up to 60% of protein lysine substitution by thialysine is observed, without appreciable effects on cell viability.


Asunto(s)
Cisteína/análogos & derivados , Escherichia coli/metabolismo , Lisina/metabolismo , Proteínas Bacterianas/biosíntesis , Proteínas Bacterianas/metabolismo , Cisteína/metabolismo , Cisteína/farmacología , Escherichia coli/genética , Escherichia coli/crecimiento & desarrollo , Mutación
20.
Ital J Biochem ; 32(1): 19-27, 1983.
Artículo en Inglés | MEDLINE | ID: mdl-6411652

RESUMEN

Utilization of thialysine and selenalysine for protein synthesis by a lysine requiring E. coli mutant was studied. Incorporation into proteins of thialysine or selenalysine, added to culture medium together with lysine, becomes evident when the amount of available lysine in the medium is highly reduced, that is the mutant utilizes the isologs only after all the available natural aminoacid has been utilized. Compared to selenalysine, thialysine is better utilized; when both isologs are present in the medium at equal concentrations, up to 46% of protein lysine is substituted by thialysine and only 12% by selenalysine.


Asunto(s)
Cisteína/análogos & derivados , Escherichia coli/metabolismo , Lisina/análogos & derivados , Lisina/metabolismo , Compuestos de Organoselenio , Selenio/metabolismo , Cisteína/metabolismo , Biosíntesis de Proteínas , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA